# Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer

> **NCT00857246** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 30 (actual)

## Conditions studied

- Gastric Cancer
- Stomach Cancer

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Irinotecan
- **DRUG:** Cisplatin
- **PROCEDURE:** Surgery
- **DRUG:** 5-FU
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00857246
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2011-09
- **Final completion:** 2015-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857246, "Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00857246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*